Nad Plus Nasal Spray
Nicotinamide adenine dinucleotide (NAD+) is a central coenzyme present in all living cells, serving as a critical electron transporter and substrate for key metabolic signaling enzymes. PX1 Research supplies high-purity NAD+ formulations, including optimized solutions designed for intranasal research models, enabling rigorous, reproducible investigation in laboratory settings.
Quick answer
Nicotinamide adenine dinucleotide (NAD+) is a central coenzyme present in all living cells, serving as a critical electron transporter and substrate for key metabolic signaling enzymes. PX1 Research supplies high-purity NAD+ formulations, including optimized solutions designed for intranasal research models, enabling rigorous, reproducible investigation in laboratory settings.
Key takeaways
- NAD plus nasal spray refers to a specialized liquid research formulation of the coenzyme nicotinamide adenine dinucleotide ([NAD+](/research-peptides/nad-plus)) prepared for intranasal administration in preclinical animal and cell-line research models.
- At the cellular level, nicotinamide adenine dinucleotide acts as a vital cofactor for key metabolic machinery.
- Systemic administration of [NAD+](/research-peptides/nad-plus) via intraperitoneal or intravenous routes in rodent models frequently faces enzymatic degradation in circulation and poor permeability across the blood-brain barrier (BBB).
- Literature evaluating intranasal [NAD+](/research-peptides/nad-plus) applications encompasses a broad array of disease models, cellular biology assays, and organ-system inquiries.
What is NAD Plus Nasal Spray in Laboratory Research?
NAD plus nasal spray refers to a specialized liquid research formulation of the coenzyme nicotinamide adenine dinucleotide (NAD+) prepared for intranasal administration in preclinical animal and cell-line research models. Designed to cross the nasal mucosal membrane to investigate central nervous system uptake, this research compound provides lab investigators with a tool to evaluate cellular bioenergetics, sirtuin activation, and PARP enzymatic activity without reliance on invasive systemic injections.
In preclinical settings, researchers utilize nad plus nasal spray research formulations to investigate how direct administration via the nasal passage influences tissue coenzyme concentration, mitochondrial bioenergetics, and metabolic homeostasis. As an essential dinucleotide composed of adenine and nicotinamide bases, NAD+ serves both as an electron donor/acceptor pair (NAD+/NADH) in redox reactions and as a sacrificial substrate for signaling proteins involved in cellular maintenance.
To maintain experimental rigor, laboratory evaluation of intranasal coenzyme delivery requires high analytical purity, strict endotoxin controls, and standardized concentration profiles. PX1 Research provides research-grade NAD+ solutions specifically formulated for analytical stability, allowing investigators to generate consistent, reproducible data across diverse experimental setups.
Biochemical Mechanism and Cellular Pathways of NAD+
At the cellular level, nicotinamide adenine dinucleotide acts as a vital cofactor for key metabolic machinery. It acts as an electron carrier within glycolytic pathways, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation. Beyond its classical role in ATP generation, NAD+ functions as an essential substrate for three distinct families of regulatory enzymes: sirtuins (SIRT1–SIRT7), poly(ADP-ribose) polymerases (PARPs), and cyclic ADP-ribose synthases (CD38 and CD157).
Preclinical studies suggest that intracellular levels of NAD+ decline during cellular stress and senescence assays. When NAD+ availability diminishes, sirtuin activity decreases, which alters downstream transcriptional regulation of mitochondrial biogenesis, oxidative stress responses, and inflammatory signaling cascades. Researchers interested in broader metabolic targets often investigate complementary compounds across our full catalog of all peptides and cofactors.
By supplying exogenous NAD+ directly to target tissues in animal models, researchers can evaluate the rate of enzyme activation, the kinetics of intracellular uptake, and the downstream expression of key metabolic genes. These mechanisms are evaluated in vitro and in animal models to understand fundamental cellular signaling pathways.
Rationale for Intranasal Delivery in Preclinical Models
Systemic administration of NAD+ via intraperitoneal or intravenous routes in rodent models frequently faces enzymatic degradation in circulation and poor permeability across the blood-brain barrier (BBB). Intranasal delivery routes leverage the direct anatomical pathways connecting the nasal mucosa to the olfactory bulb and trigeminal nerve pathways, bypassing hepatic first-pass metabolism and systemic clearance.
In vivo rodent assays demonstrate that intranasal administration of dinucleotide solutions results in rapid detection of elevated NAD+ levels within specific CNS regions, including the cortex, hippocampus, and striatum. This targeted delivery profile makes intranasal research models particularly valuable for investigators examining neuroenergetics, neuroinflammation, and ischemic cellular stress responses.
Furthermore, non-invasive mucosal exposure allows for repeated dosing protocols in long-term behavioral or metabolic preclinical studies without the confounding physiological stress caused by repeated parenteral injections. Detailed experimental protocols for CNS coenzyme uptake can be referenced in our expanded technical guide on NAD+ sirtuin activation and metabolic signaling.
Overview of Preclinical Literature and Research Applications
Literature evaluating intranasal NAD+ applications encompasses a broad array of disease models, cellular biology assays, and organ-system inquiries. In rodent models of cerebral ischemia, intranasal NAD+ administration delivered within specific post-reperfusion time windows demonstrated a marked reduction in neuronal cell loss and microglial activation in cortex tissue.
In vitro data indicate that elevated extracellular NAD+ can be transported across cell membranes via specific transporters or broken down into precursors like nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) before intracellular re-synthesis. In preclinical neurodegenerative models—such as transgenic mice expressing markers for Alzheimer's or Parkinson's pathology—intranasal NAD+ administration has been observed to preserve mitochondrial membrane potential and decrease markers of DNA strand breakage.
Additionally, preclinical investigations focus on the role of NAD+ in modulating metabolic dysfunction. By restoring nuclear and mitochondrial NAD+ pools, researchers observe enhanced SIRT1 signaling, which in turn deacetylates PGC-1alpha, promoting mitochondrial biogenesis and mitigating oxidative degradation in skeletal muscle and neural tissues.
Comparative Analysis with Related Research Compounds
When designing preclinical trials focused on mitochondrial maintenance and metabolic signaling, investigators frequently compare NAD+ with other targeted compounds. While NAD+ serves as a direct coenzyme substrate, precursor molecules like NMN operate upstream in the salvage pathway, relying on enzymatic conversion by nicotinamide phosphoribosyltransferase (NAMPT).
In contrast, small-molecule peptides targeting mitochondrial outer or inner membranes act through independent mechanisms. For instance, researchers studying mitochondrial energy production often compare NAD+ signaling with the peptide SS-31, which directly targets cardiolipin to preserve mitochondrial cristae structure, or MOTS-c, a mitochondria-derived peptide that regulates nuclear gene expression during metabolic stress.
Understanding these mechanistic differences allows researchers to structure comparative or combination protocols in vitro, evaluating whether direct coenzyme supplementation via NAD+ nasal spray works synergistically with membrane-stabilizing compounds to optimize cellular bioenergetics.
Laboratory Handling, Reconstitution, and Storage Protocols
To preserve the chemical stability of NAD+ intranasal solutions, researchers must follow strict storage and handling standards. Lyophilized NAD+ powder or concentrated raw coenzyme materials are highly hygroscopic and susceptible to hydrolytic degradation if exposed to moisture, ambient heat, or unbuffered aqueous environments for extended periods.
Upon receipt, un-reconstituted NAD+ research compounds should be stored in a dark, desiccated environment at -20°C. For intranasal formulation, reconstitution should be performed using sterile, buffered saline (such as 0.9% sodium chloride, pH-adjusted to 6.5–7.4) or specialized intranasal carrier vehicles designed for preclinical laboratory use. Reconstituted liquid aliquots should be maintained at 4°C for short-term experimentation (under 48 hours) or flash-frozen at -80°C for longer storage to prevent spontaneous breakdown into nicotinamide.
Researchers should avoid repeated freeze-thaw cycles, as degradation of the dinucleotide bond alters concentration accuracy and introduces baseline variations into experimental data. Standard operating procedures for laboratory handling are detailed in our comprehensive research hub.
Analytical Purity Verification: RP-HPLC and Mass Spectrometry
Experimental reproducibility relies entirely on compound purity and exact structural verification. At PX1 Research, every lot of research-grade NAD+ undergoes exhaustive analytical testing conducted by independent, accredited laboratories before distribution.
Purity is assessed using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring that total chemical purity exceeds 98% to 99%. Chromatographic evaluation confirms the absence of degradation products, residual solvents, or synthetic intermediate impurities that could skew cell-culture viability or receptor binding assays.
Identity verification is confirmed via Electrospray Ionization Mass Spectrometry (ESI-MS). The resultant mass spectrum provides precise mass-to-charge ratio data matching the theoretical molecular weight of oxidized nicotinamide adenine dinucleotide (C21H27N7O14P2, MW: 663.43 g/mol), verifying that structural integrity remains uncompromised during synthesis and packaging.
Endotoxin Control, ISO 17025 Standards, and Quality Assurance
In cell culture and animal research models, endotoxin contamination (lipopolysaccharides from Gram-negative bacteria) presents a major confounding variable, triggering non-specific immune activation, cytokine release, and cell death. PX1 Research enforces rigorous endotoxin screening on all research compounds utilizing chromogenic Limulus Amebocyte Lysate (LAL) assays.
Our target compounds are manufactured in cGMP-compliant facilities operating under strict environmental quality controls. Analytical testing is performed in third-party ISO 17025 accredited laboratories to ensure absolute objectivity and regulatory compliance.
Every item dispatched includes accessible documentation verifying batch-specific testing results. Principal investigators can review complete assay reports, HPLC chromatograms, and mass spec data to meet institutional oversight requirements and ensure consistent performance in laboratory experiments.
USA Manufacturing, Lot Traceability, and Procurement
PX1 Research is committed to serving the scientific community with USA-manufactured research compounds adhering to transparent quality standards. Every container of NAD+ intranasal solution or powder features full lot traceability, linking final packaging back to primary synthesis batches and raw material sourcing.
To minimize downtime in active laboratory studies, orders ship same-day (Monday through Friday) directly from our distribution hubs in California and Arizona. This dual-location fulfillment setup minimizes transit times and ensures temperature-sensitive research compounds arrive securely at institutional facilities.
For academic institutions, biotechnology enterprises, and government research facilities requiring larger order volumes or ongoing supply contracts, PX1 Research offers streamlined procurement options through our dedicated wholesale program.
Frequently Asked Questions
What is nad plus nasal spray intended for?
Nad plus nasal spray is supplied strictly as a research-grade compound for in vitro, ex vivo, and animal model laboratory investigation. It is intended to study cellular bioenergetics, CNS coenzyme transport, and enzymatic signaling, and is not for human or veterinary use.
How is nad plus nasal spray supplied for laboratory use?
NAD+ for intranasal research is supplied either as a pre-formulated, sterile research solution calibrated for laboratory administration devices or as a high-purity lyophilized powder requiring reconstitution in buffered saline.
Why is intranasal delivery studied for NAD+ in preclinical research?
Preclinical researchers utilize intranasal delivery models because the nasal mucosa provides a direct pathway to CNS tissue via the olfactory and trigeminal nerve pathways, avoiding systemic hepatic metabolism and blood-brain barrier restriction.
What enzymes interact directly with NAD+ in cell culture assays?
NAD+ acts as an essential cofactor and sacrificial substrate for several enzymatic families, including class III histone deacetylases (sirtuins SIRT1–7), poly(ADP-ribose) polymerases (PARPs), and cyclic ADP-ribose synthases (CD38, CD157).
How does PX1 Research verify the purity of nad plus nasal spray?
Every lot of NAD+ undergoes independent third-party analytical testing, including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity verification (>98%) and Mass Spectrometry (MS) for exact molecular weight identity confirmation.
What endotoxin limits apply to research-grade NAD+ compounds?
PX1 Research subjects all compound batches to Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels fall below stringent threshold limits (<0.01 EU/mg), preventing non-specific inflammatory responses in cellular assays.
What are the storage recommendations for nad plus nasal spray solutions?
Lyophilized powder should be stored at -20°C in a desiccated environment. Reconstituted or pre-formulated liquid solutions should be kept at 4°C for immediate use or flash-frozen at -80°C to avoid hydrolysis and maintain compound stability.
How does NAD+ compare to NMN in metabolic laboratory studies?
NAD+ is the active dinucleotide coenzyme itself, whereas NMN (nicotinamide mononucleotide) is an immediate precursor that requires enzymatic conversion via the salvage pathway. Investigators select between them depending on whether they wish to study direct enzymatic consumption or precursor transport kinetics.
Where can I obtain a Certificate of Analysis (COA) for my lot?
PX1 Research provides lot-specific Certificates of Analysis (COAs) for every product. COAs detailing HPLC purity profiles, mass spectrometry data, and endotoxin levels are available directly on our website or by contacting lab support.
What are the shipping times and origin locations for PX1 Research orders?
Orders placed Monday through Friday ship same-day from our primary fulfillment centers located in California and Arizona, ensuring rapid, reliable delivery to domestic research institutions.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.